Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
2018 ◽
Vol 15
(7)
◽
pp. S160
◽
2015 ◽
Vol 14
(5)
◽
pp. 576-586
◽
2017 ◽
Vol 5
(2)
◽
pp. 200-210
◽
1988 ◽
Vol 11
(4)
◽
pp. 247-264
◽